Follicular lymphoma trials in Russia

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

  Where

  Moscow, Omsk, Pushkin, Saint Petersburg, Yaroslavl

  Age

  18 years and over

  People

  453 worldwide

  Run by

  Pfizer

  See details and how to joinNCT03460977 · EU 2023-509179-18-00